PMDA — authorised 20 January 2022
- Marketing authorisation holder: Argenx Japan K.K.
- Status: approved
🇯🇵 Vyvgart in Japan
PMDA authorised Vyvgart on 20 January 2022
Marketing authorisation
Vyvgart in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Vyvgart approved in Japan?
Yes. PMDA authorised it on 20 January 2022.
Who is the marketing authorisation holder for Vyvgart in Japan?
Argenx Japan K.K. holds the Japanese marketing authorisation.